Identification of a severe bleeding disorder in humans caused by a mutation in CalDAG-GEFI

Insight from William Muller
Adhesion of calcein-AM-labeled platelets to fibrillar collagen under flow (750 s -1 ) from a homozygous (HOM), heterozygous (HET), and healthy (Ctl) subject. Percentage of covered area was assessed over 300 seconds (left). The initial 60 seconds are magnified (right).
A gallon of sweat to make a pint of blood
From multipotent stem cells, the hematopoietic system undergoes continuous differentiation to generate a remarkable array of mature cells throughout life. These hematopoietic stem cells (HSCs) hold promise for cell therapy through bone marrow transplantation, as well as serving as a paradigm for stem cell biology, so they are the focus of intense investigation. However, studying these cells is impeded by their scarcitythey are present at around 1 per 50,000 bone marrow cells and there is still no reliable method to expand them in vitro.
Gazit et al. analyzed data from hundreds of microarrays to identify sets of genes uniquely expressed in individual hematopoietic cell types. They then mined the HSC-specific gene list to identify candidate markers for HSCs that might be useful to study these rare cells. They found that when mCherry was knocked-in to the locus of one of these genes, Fgd5, red fluorescence could be used to purify virtually all of the HSCs, as rigorously tested by both phenotypic and functional criteria. Moreover, they inserted a tamoxifen-inducible Cre recombinase into the locus, offering the possibility of using this mouse line for HSC-specific deletion or lineage tracing.
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There are a number of genes that are highly expressed in HSCs, but most of these are shared with their immediate downstream progeny. Thus, establishing these Fdg5-reporter mouse lines and demonstrating the high and specific expression pattern that can be achieved with insertions into this locus is a significant contribution to the field. The power of the study lies in the utility of the mouse lines, but it also provides a benchmark for such reporters in the future.
This strategy could also be exploited to generate other lineage-specific reporter or deleter mouse lines. The bioinformatics approach generates sets of genes that can serve as what my lab previously termed "cellular fingerprints" that can be used as cell-type identifiers, and some may confer unique cellular properties that merit functional investigation.
Whereas General George S. Patton said, "A pint of sweat saves a gallon of blood," here we have a valiant effort, undoubtedly representing gallons of sweat, that will be useful for making a pint or more of blood. Rodgers et al. now show that LUBAC is essential for NF-kB activation in mouse embryonic fibroblasts (MEFs) stimulated with LPS, but dispensable in bone marrow-derived macrophages (BMDMs). They also demonstrate that the activation of caspase 1 by the complex formed by NLRP3 (NLR family, pyrin domain containing 3, encoded by CIAS1) and ASC (apoptosis-associated speck-like protein containing CARD) is dependent on LUBAC in LPS-primed, nigericin-stimulated macrophages. Using different approaches, they show that the formation of the NLPR3-ASC complex in response to nigericin stimulation involves the linear ubiquitination of ASC. Linear ubiquitination is required for the transformation of pro-IL-1b into secreted and bioactive IL-1b by caspase 1. HOIL1-deficient mice are protected against LPS toxicity in vivo.
This work reveals new aspects of linear ubiquitination in mice. First, it reveals a cell specificity of LUBAC in the activation of NF-kB. It shows, for the first time, that LUBAC is dispensable for NF-kB activation in certain cell types, although the mechanism involved remains elusive. Second, it shows that LUBAC plays an essential role in the activation of caspase-1 upon stimulation of the NLRP3-ASC inflammasome. This finding extends the cellular function of LUBAC and linear ubiquitination to processes independent of NEMO and the NF-kB pathway. If extended to human cells, these findings would provide a novel angle from which to tackle the pathogenesis of the autoinflammation, immunodeficiency, and amylopectinosis observed in patients with inherited HOIL-1 deficiency. Surprisingly, these patients also display a cell-specific pattern of response to IL-1b, with hyperresponsive monocytes and hyporesponsive fibroblasts. LUBACdependent NLRP3 activation would also pave the way for the targeting of linear ubiquitination in patients with autoinflammatory diseases due to mutations of NLRP3, such as cryopyrin-associated periodic syndrome (CAPS) and Muckle-Wells syndrome.
